Local neurohumoral regulation in the transition to isolated diastolic heart failure in hypertensive heart disease: Absence of AT1 receptor downregulation and 'overdrive' of the endothelin system

Cardiovascular Research

Volumn 46, Issue 3, 2000, Pages 421-432

  Yamamoto, Kazuhiro ^a   Masuyama, Tohru ^a   Sakata, Yasushi ^a   Doi, Reiko ^a   Ono, Keiko ^a   Mano, Toshiaki ^a   Kondo, Hiroya ^a   Kuzuya, Tsunehiko ^a   Miwa, Takeshi ^b   Hori, Masatsugu ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Angiotensin; Endothelins; Heart failure; Hypertension; Natriuretic peptide

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; ENDOTHELIN; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; NATRIURETIC FACTOR; NEUROHORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; GENE EXPRESSION; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEMODYNAMICS; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANALYSIS OF VARIANCE; ANIMALS; ASPARTIC ENDOPEPTIDASES; ATRIAL NATRIURETIC FACTOR; DIASTOLE; ECHOCARDIOGRAPHY; ENDOTHELIN-1; ENDOTHELINS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; HEART FAILURE, CONGESTIVE; IMMUNOHISTOCHEMISTRY; MALE; METALLOENDOPEPTIDASES; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; PEPTIDYL-DIPEPTIDASE A; PROTEIN PRECURSORS; RATS; RATS, INBRED DAHL; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RECEPTORS, ANGIOTENSIN; RECEPTORS, ENDOTHELIN; RENIN-ANGIOTENSIN SYSTEM; RNA, MESSENGER;

EID: 19244378403     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(00)00024-9     Document Type: Article

References (45)

1. Sakai S., Miyauchi T., Kobayashi M., Yamaguchi I., Goto K., Sugishita Y. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature. 384:1996;353-355.
2. Yamazaki T., Shiojima I., Komuro I., Nagai R., Yazaki Y. Involvement of the renin-angiotensin system in the development of left ventricular hypertrophy and dysfunction. J. Hypertens. 12:(Suppl 9):1994;S23-S27.
3. Yasue H., Yoshimura M., Sumida H., et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation. 90:1994;195-203.
4. Yamamoto K., Burnett J.C. Jr., Redfield M.M. Effect of endogenous natriuretic peptide system on ventricular and coronary function in failing heart. Am. J. Physiol. 273:1997;H2406-H2414.
5. Pitt B., Segal R., Martinez F.A., et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet. 349:1997;747-752.
6. Sakai S., Yorikane R., Miyauchi T., et al. Altered production of endothelin-1 in the hypertrophied rat heart. J. Cardiovasc. Pharmacol. 26:(Suppl 3):1995;S452-S455.
7. Nio Y., Matsubara H., Murasawa S., Kanasaki M., Inada M. Regulation of gene transcription of angiotensin II. receptor subtypes in myocardial infarction. J. Clin. Invest. 95:1995;46-54.
8. Asano K., Dutcher D.L., Port J.D., et al. Selective downregulation of the angiotensin I.I. AT1-receptor subtype in failing human ventricular myocardium. Circulation. 95:1997;1193-1200.
9. Ponicke K., Vogelsang M., Heinroth M., et al. Endothelin receptors in the failing and nonfailing human heart. Circulation. 97:1998;744-751.
10. Loffler B.M., Roux S., Kalina B., Clozel M., Clozel J.P. Influence of congestive heart failure on endothelin levels and receptors in rabbits. J. Mol. Cell. Cardiol. 25:1993;407-416.
11. Vasan R.S., Benjamin E.J., Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J. Am. Coll. Cardiol. 26:1995;1565-1574.
12. Vasan R.S., Larson M.G., Benjamin E.J., Evans J.C., Reiss C.K., Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction. J. Am. Coll. Cardiol. 33:1999;1948-1955.
13. Senni M., Tribouilloy C.M., Rodeheffer R.J., et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation. 98:1998;2282-2289.
14. Doi R., Masuyama T., Yamamoto K., et al. Development of different phenotypes of hypertensive heart failure - systolic versus diastolic failure in Dahl salt-sensitive rats. J Hypertens. 18:2000;111-120.
15. Weinberg E.O., Schoen F.J., George D., et al. Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis. Circulation. 90:1994;1410-1422.
16. Brooks W.W., Bing O.H.L., Robinson K.G., Slawsky M.T., Chaletsky D.M., Conrad C.H. Effect of angiotensin-converting enzyme inhibition on myocardial fibrosis and function in hypertrophied and failing myocardium from the spontaneous hypertensive rat. Circulation. 96:1997;4002-4010.
17. Shimizu G., Hirota Y., Kita Y., Kawamura K., Saito T., Gaasch W.H. Left ventricular midwall mechanics in systemic arterial hypertension. Circulation. 83:1991;1676-1684.
18. Stegemann H., Stalder K.H. Determination of hydroxyproline. Clin. Chim. Acta. 18:1967;267-273.
19. Kubo A., Minamino N., Isumi Y., et al. Production of adrenomedullin in macrophage cell line and peritoneal macrophage. J. Biol. Chem. 273:1998;16730-16738.
20. Shunkert H., Dzau V.J., Tang S.S., Hirsch A.T., Apstein C.S., Lorell B.H. Increased rat cardiac angiotensin-converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy: effect on coronary resistance, contractility and relaxation. J. Clin. Invest. 86:1990;1913-1920.
21. Suzuki J., Matsubara H., Urakami M., Inada M. Rat angiotensin I.I. (type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy. Circ. Res. 73:1993;439-447.
22. Lopez J.J., Lorell B.H., Ingelfinger J.R., et al. Distribution and function of cardiac angiotensin AT1- and AT2-receptor subtypes in hypertrophied rat hearts. Am. J. Physiol. 267:1994;H844-H852.
23. Yamazaki T., Komuro I., Kudoh S., et al. Angiotensin I.I. partly medicates mechanical stress-induced cardiac hypertrophy. Circ. Res. 77:1995;258-265.
24. Weber K.T., Sun Y., Guarda E. Structural remodeling in hypertensive heart disease and the role of hormones. Hypertension. 23:1994;869-877.
25. Richer C., Fornes P., Cazaubon C., Domergue V., Nisato D., Giudicelli J.F. Effects of long-term angiotensin II. AT1 receptor blockade on survival, hemodynamics and cardiac remodeling in chronic heart failure in rats. Cardiovasc. Res. 41:1999;100-108.
26. Spinale F.G., de Gasparo M., Whitebread S., et al. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: 1. effects on left ventricular performance and neurohumoral systems. Circulation. 96:1997;2385-2396.
27. McKelvie R.S., Yusuf S., Pericak D., et al. Comparison of candesartan, enalapril, and their combination in congestive heart failure: Randomized Evaluation of Strategies for the Left Ventricular Dysfunction (RESOLVD) pilot study. Circulation. 100:1999;1056-1064.
28. Sakata Y., Masuyama T., Yamamoto K., et al. Angiotensin I.I. receptor blockade does not suppress compensatory hypertrophy but prevent excess hypertrophy contributing to transition to heart failure in hypertensive rats. J. Am. Coll. Cardiol. 33:(Suppl A):1999;284A. abstract.
29. Fraccarollo D., Hu K., Galuppo P., Gaudron P., Ertl G. Chronic endothelin receptor blockade attenuate progressive ventricular dilatation and improves cardiac function in rats with myocardial infarction: possible involvement of myocardial endothelin system in ventricular remodeling. Circulation. 96:1997;3963-3973.
30. Arai M., Yoguchi A., Iso T., et al. Endothelin-1 and its binding sites are upregulated in pressure overload cardiac hypertrophy. Am. J. Physiol. 268:1995;H2084-H2091.
31. Thibault G., Arguin C., Garcia R. Cardiac endothelin-1 content and receptor subtype in spontaneously hypertensive rats. J. Mol. Cell Cardiol. 27:1995;2327-2336.
32. Iwanaga Y., Kihara Y., Hasegawa K., et al. Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats. Circulation. 98:1998;2065-2073.
33. Harada M., Itoh H., Nakagawa O., et al. Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy: evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes. Circulation. 96:1997;3737-3744.
34. Inoko M., Kihara Y., Morii I., Fujiwara H., Sasayama S. Transition from compensatory hypertrophy to dilated, failing left ventricles in Dahl salt-sensitive rats. Am. J. Physiol. 267:1994;H2471-H2482.
35. Nakagawa O., Ogawa Y., Itoh H., et al. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy: evidence for brain natriuretic peptide as an 'emergency' cardiac hormone against ventricular overload. J. Clin. Invest. 96:1995;1280-1287.
36. Harada K., Komuro I., Shiojima I., et al. Pressure overload induces cardiac hypertrophy in angiotensin I.I. type 1A receptor knockout mice. Circulation. 97:1998;1952-1959.
37. Tso J.Y., Sun X.H., Kao T.H., Reece K.S., Wu R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: Genomic complexity and molecular evolution of the gene. Nucleic Acids Res. 13:1985;2485-2502.
38. Sakurai T., Yanagisawa M., Inoue A., et al. cDNA cloning, sequence analysis and tissue distribution of rat preproendothelin-1 mRNA. Biochem. Biophys. Res. Commun. 175:1991;44-47.
39. Lin H.Y., Kaji E.H., Winkel G.K., Ives H.E., Lodish H.F. Cloning and functional expression of a vascular smooth muscle endothelin 1 receptor. Proc. Natl. Acad. Sci. USA. 88:1991;3185-3189.
40. Sakurai T., Yanagisawa M., Takuwa Y., et al. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature. 348:1990;732-735.
41. Shimada K., Takahashi M., Tanzawa K. Cloning and functional expression of endothelin-converting enzyme from rat endothelial cells. J. Biol. Chem. 269:1994;18275-18278.
42. Koike G., Krieger J.E., Jacob H.J., Mukoyama M., Pratt R.E., Dzau V.J. Angiotensin-converting enzyme and genetic hypertension: cloning of rat cDNA and characterization of the enzyme. Biochem. Biophys. Res. Commun. 198:1994;380-386.
43. Murphy T.J., Alexander R.W., Griendling K.K., Runge M.S., Bernstein K.E. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature. 351:1991;233-236.
44. Flynn T.G. The elucidation of the structure of atrial natriuretic factor, a new peptide hormone. Can. J. Physiol. Pharmacol. 65:1987;2013-2020.
45. Kojima M., Minamino N., Kangawa K., Matsuo H. Cloning and sequence analysis of cDNA encoding a precursor for rat brain natriuretic peptide. Biochem. Biophys. Res. Commun. 159:1989;1420-1426.